Using our analysis, we find that the highest scoring MYCN peptide (TVRPKNAAL) has predicted binding to 9 HLA alleles, representing 58.1% of the population, and we expect analysis of more neuroblastoma tumor specimens will validate this prediction. This evidence concerns the gene MYCN and neoplasm.